The mission of the MRI Research Institute (MRIRI) is to develop and apply MRI in conjunction with other technologies (including pathology, PET, and CT) to the study of tissues, disease diagnosis, therapy guidance, and patient monitoring. We seek to innovate effective and accurate MRI Plus technologies to improve the sensitivity of disease detection and characterization methods, and advance quantitative methods for precision medicine. We facilitate the translation of technology from benchtop to bedside to broadly impact the practice of medicine worldwide.
The MRIRI’s members are engineers, scientists, and physicians with multidisciplinary expertise in biology, computer science, electrical engineering, mathematics, medicine, and physics, among other areas. We form interdisciplinary teams to conduct basic research, translational research, and clinical research to tackle complex biomedical problems and address unmet medical needs. While diagnosing and treating patients, our physicians have been identifying disease-specific needs to improve imaging capabilities such as sensitivities, space-time resolutions, and contrasts. Our engineers and scientists have been developing MRI Plus technology hardware and software to gain unprecedented detail, speed, and sensitivity. Together, we bridge the gap between engineering and medicine, and capitalize on these technological achievements to advance healthcare. Current National Institutes of Health-funded MRIRI MRI plus projects include diagnosis and/or therapy studies of brain diseases (Alzheimer disease, Parkinson disease, multiple sclerosis, cerebrovascular disease), breast cancer, heart disease, liver diseases, and atherosclerotic plaque.